SCHEMBL6807017

SCHEMBL6807017

CCOC(=O)C(C(=O)O)c1c(CC)cc(C)cc1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.41
SRC P12931 1/20 0.40
PIN1 Q13526 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
SLC7A5 Q01650 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12774634 0.91 MMP8 (0.40) MMP8PIN1MEN1KMT2ANPC1
SCHEMBL3151639 0.87 SRC (0.41) SRCALDH1A1KDM4EHPGDRAB9A
SCHEMBL6807015 0.82 TAS1R3 (0.40) MMP8ALDH1A1KDM4ESLC7A5CYP1A2
SCHEMBL1537460 0.81 MMP8 (0.43) MMP8PIN1MEN1KMT2ANPC1
SCHEMBL6806730 0.76 ALOX15 (0.35) SRCMEN1KMT2AALDH1A1KDM4E
SCHEMBL8795536 0.74 NLRP3 (0.44) MMP8PIN1MEN1KMT2ANPC1
SCHEMBL28547539 0.73 KMT2A (0.48) MEN1KMT2ANPC1ALDH1A1KDM4E
SCHEMBL6808060 0.71 HTT (0.43) MEN1KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL23944802 0.71 MMP8 (0.42) MMP8PIN1MEN1KMT2ANPC1
SCHEMBL5439558 0.70 TSHR (0.39) ALDH1A1KDM4EHPGDRAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111440192-B Method for preparing pinoxaden intermediate through micro-channel 山东华科化工有限公司 2022-11-25 CN disclosed
CN-111440192-A Method for preparing pinoxaden intermediate through micro-channel 山东华科化工有限公司 2020-07-24 CN disclosed
US-20040198797-A1 Process for the preparation of herbicidal derivatives MAETZKE THOMAS (CH) 2004-10-07 US disclosed
EP-1183317-B1 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2003-09-17 EP disclosed
US-6552187-B1 Cyclization condensation of arylmalonic acid diamides or arylmalonic acid monoamides with hydrazine derivatives forming substituted 3-hydroxy-4-aryl-5-oxopyrazolines; high yield and purity SYNGENTA CROP PROTECTION, INC. 2003-04-22 US disclosed
EP-1183317-A2 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES Syngenta Participations AG (CH) 2002-03-06 EP disclosed
WO-2000078881-A2 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES SYGENTA PARTICIPATIONS AG (CH) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198797-A1 Process for the preparation of herbicidal derivatives CBR3, CBR1, CYC1 MMP8 3791/4885SRC 3202/4885PIN1 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.